Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qianwen Mu

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Materials Today. Bio|July 29, 2024
Nanotechnology for tau pathology in Alzheimer's diseaseRongrong Ma, Qianwen Mu, Yue Xi, et al.
Acta Pharmaceutica Sinica. B|May 25, 2026
Nanotechnology-driven STING regulation for on-demand therapyQianwen Mu, Qihang Huang, Haolan Deng, et al.
Nature Communications|March 31, 2026
A biomimetic nanodisc system selectively activates type I interferons by nonclassical STING pathway for cancer immunotherapyQianwen Mu, Haolan Deng, Shuo Li, et al.
European Journal of Medicinal Chemistry|November 21, 2020
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatmentRui Zhang, Heng Li, Xianglei Zhang, et al.
Nano Letters|April 11, 2025
Epigenetically Reprogrammed Nanovesicles as Inverse Vaccines for Antigen-Specific Immune Tolerance in Autoimmune DiseasesYue Xi, Huifeng Ma, Xue Liu, et al.
Science Advances|March 27, 2026
Cold atmospheric plasma-engineered nanovaccine with spatiotemporal sequential immunization reprograms antitumor immunityShuo Li, Peiyu Wang, Zhenyu Wu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Materials Today. Bio|July 29, 2024
Nanotechnology for tau pathology in Alzheimer's diseaseRongrong Ma, Qianwen Mu, Yue Xi, et al.
Acta Pharmaceutica Sinica. B|May 25, 2026
Nanotechnology-driven STING regulation for on-demand therapyQianwen Mu, Qihang Huang, Haolan Deng, et al.
Nature Communications|March 31, 2026
A biomimetic nanodisc system selectively activates type I interferons by nonclassical STING pathway for cancer immunotherapyQianwen Mu, Haolan Deng, Shuo Li, et al.
European Journal of Medicinal Chemistry|November 21, 2020
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatmentRui Zhang, Heng Li, Xianglei Zhang, et al.
Nano Letters|April 11, 2025
Epigenetically Reprogrammed Nanovesicles as Inverse Vaccines for Antigen-Specific Immune Tolerance in Autoimmune DiseasesYue Xi, Huifeng Ma, Xue Liu, et al.
Science Advances|March 27, 2026
Cold atmospheric plasma-engineered nanovaccine with spatiotemporal sequential immunization reprograms antitumor immunityShuo Li, Peiyu Wang, Zhenyu Wu, et al.
Pageof 1